文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

四(2-萘基)四氰基卟吩嗪及其铁配合物作为抗癌光动力疗法光敏剂的比较分析

Comparative Analysis of Tetra(2-naphthyl)tetracyano-porphyrazine and Its Iron Complex as Photosensitizers for Anticancer Photodynamic Therapy.

作者信息

Shestakova Lydia N, Lyubova Tatyana S, Lermontova Svetlana A, Belotelov Artem O, Peskova Nina N, Klapshina Larisa G, Balalaeva Irina V, Shilyagina Natalia Y

机构信息

Institute of Biology and Biomedicine, Lobachevsky State University, Gagarin Ave., 23, 603950 Nizhny Novgorod, Russia.

Razuvaev Institute of Organomettalic Chemistry, Russian Academy of Sciences, St. Tropinina, 49, 603137 Nizhny Novgorod, Russia.

出版信息

Pharmaceutics. 2022 Nov 30;14(12):2655. doi: 10.3390/pharmaceutics14122655.


DOI:10.3390/pharmaceutics14122655
PMID:36559148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9786040/
Abstract

Photodynamic therapy (PDT) is a rapidly developing modality of primary and adjuvant anticancer treatment. The main trends today are the search for new effective photodynamic agents and the creation of targeted delivery systems with the function of controlling the release of the agent in the tumor. Recently, the new group of cyanoarylporphyrazine dyes was reported, which combine the properties of photosensitizers and sensors of the local microenvironment. Such unique characteristics allow the release of the photosensitizer from the transport carrier to be assessed in real time in vivo. The aim of the present work was to compare the photophysical and photobiological properties of tetra(2-naphthyl)tetracyanoporphyrazine and its newly synthesized Fe(II) complex. We have shown that the chelation of the Fe(II) cation with the porphyrazine macrocycle leads to a decrease in molar extinction and an increase in the quantum yield of fluorescence and photostability. We demonstrate that the iron cation significantly affects the rate of dye accumulation in cells, the dark toxicity and photodynamic activity, and the direction of the changes depends on the particular cell line. However, in all the cases, the photodynamic index of a metal complex was higher than that of a metal-free base. In general, both of the compounds were found to be very promising for PDT, including for the use with transport delivery systems, and can be recommended for further in vivo studies.

摘要

光动力疗法(PDT)是一种快速发展的原发性和辅助性抗癌治疗方式。当今的主要趋势是寻找新的有效光动力剂以及创建具有控制药物在肿瘤中释放功能的靶向递送系统。最近,报道了一类新的氰基芳基卟啉嗪染料,它们兼具光敏剂和局部微环境传感器的特性。这种独特的特性使得能够在体内实时评估光敏剂从运输载体中的释放情况。本研究的目的是比较四(2-萘基)四氰基卟啉嗪及其新合成的铁(II)配合物的光物理和光生物学性质。我们已经表明,铁(II)阳离子与卟啉嗪大环的螯合导致摩尔消光系数降低,荧光量子产率和光稳定性增加。我们证明铁阳离子显著影响染料在细胞中的积累速率、暗毒性和光动力活性,并且变化方向取决于特定的细胞系。然而,在所有情况下,金属配合物的光动力指数都高于无金属碱。总体而言,发现这两种化合物对于光动力疗法都非常有前景,包括与运输递送系统一起使用,并且可以推荐用于进一步的体内研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa7f/9786040/5f90256e7074/pharmaceutics-14-02655-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa7f/9786040/6110b7a5f40f/pharmaceutics-14-02655-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa7f/9786040/7eade5f9dba3/pharmaceutics-14-02655-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa7f/9786040/36fae4dc9b2f/pharmaceutics-14-02655-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa7f/9786040/7bc02ad98028/pharmaceutics-14-02655-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa7f/9786040/6999cb0c9f75/pharmaceutics-14-02655-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa7f/9786040/5f90256e7074/pharmaceutics-14-02655-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa7f/9786040/6110b7a5f40f/pharmaceutics-14-02655-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa7f/9786040/7eade5f9dba3/pharmaceutics-14-02655-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa7f/9786040/36fae4dc9b2f/pharmaceutics-14-02655-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa7f/9786040/7bc02ad98028/pharmaceutics-14-02655-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa7f/9786040/6999cb0c9f75/pharmaceutics-14-02655-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa7f/9786040/5f90256e7074/pharmaceutics-14-02655-g006.jpg

相似文献

[1]
Comparative Analysis of Tetra(2-naphthyl)tetracyano-porphyrazine and Its Iron Complex as Photosensitizers for Anticancer Photodynamic Therapy.

Pharmaceutics. 2022-11-30

[2]
Cyanoarylporphyrazine dyes: multimodal compounds for personalised photodynamic therapy.

Biophys Rev. 2023-9-25

[3]
Cyanoarylporphyrazines with High Viscosity Sensitivity: A Step towards Dosimetry-Assisted Photodynamic Cancer Treatment.

Molecules. 2021-9-25

[4]
Liposomal Form of Tetra(Aryl)Tetracyanoporphyrazine: Physical Properties and Photodynamic Activity In Vitro.

J Fluoresc. 2018-3

[5]
In vivo multimodal tumor imaging and photodynamic therapy with novel theranostic agents based on the porphyrazine framework-chelated gadolinium (III) cation.

Biochim Biophys Acta Gen Subj. 2017-9-13

[6]
Exocyclically metallated tetrapyridinoporphyrazine as a potential photosensitizer for photodynamic therapy.

Photochem Photobiol Sci. 2019-10-18

[7]
Photophysical Characterization and in Vitro Phototoxicity Evaluation of 5,10,15,20-Tetra(quinolin-2-yl)porphyrin as a Potential Sensitizer for Photodynamic Therapy.

Molecules. 2016-3-31

[8]
Effect of novel porphyrazine photosensitizers on normal and tumor brain cells.

J Biophotonics. 2020-1

[9]
Heavy-Atom-Free Photosensitizers: From Molecular Design to Applications in the Photodynamic Therapy of Cancer.

Acc Chem Res. 2021-1-5

[10]
Effective delivery of porphyrazine photosensitizers to cancer cells by polymer brush nanocontainers.

J Biophotonics. 2017-9

引用本文的文献

[1]
Cyanoarylporphyrazine dyes: multimodal compounds for personalised photodynamic therapy.

Biophys Rev. 2023-9-25

[2]
Photodynamic Therapy: From the Basics to the Current Progress of -Heterocyclic-Bearing Dyes as Effective Photosensitizers.

Molecules. 2023-6-29

本文引用的文献

[1]
Nanomaterials-based photosensitizers and delivery systems for photodynamic cancer therapy.

Biomater Adv. 2022-4

[2]
Recent advances in noble metal complex based photodynamic therapy.

Chem Sci. 2022-4-1

[3]
Curcumin-loaded PEGylated mesoporous silica nanoparticles for effective photodynamic therapy.

RSC Adv. 2020-6-29

[4]
Hyaluronic Acid Nanoparticles Based on a Conjugated Oligomer Photosensitizer: Target-Specific Two-Photon Imaging, Redox-Sensitive Drug Delivery, and Synergistic Chemo-Photodynamic Therapy.

ACS Appl Bio Mater. 2019-6-17

[5]
Cyanoarylporphyrazines with High Viscosity Sensitivity: A Step towards Dosimetry-Assisted Photodynamic Cancer Treatment.

Molecules. 2021-9-25

[6]
Poly(methacrylic Acid)-Cellulose Brushes as Anticancer Porphyrazine Carrier.

Nanomaterials (Basel). 2021-8-3

[7]
Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death.

Sci Rep. 2021-3-30

[8]
Photodynamic therapy with a new bacteriochlorin derivative: Characterization and in vitro studies.

Photodiagnosis Photodyn Ther. 2021-6

[9]
Ferroptosis and Photodynamic Therapy Synergism: Enhancing Anticancer Treatment.

Trends Cancer. 2021-6

[10]
Exploiting gold nanoparticles for diagnosis and cancer treatments.

Nanotechnology. 2021-5-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索